Welcome to the Porton Newsroom
Porton Crystallization Technology Platform
Porton Crystallization Technology Platform empowers every step of drug production with crystallization.
More Than You Can Imagine — February 28th is Rare Disease Day.
At Porton, we remain deeply committed to advancing care for those affected by rare diseases, and we are offering our continued support as we move forward together, enabling earlier access to good medicines.
How to Perform the Development of Conventional/Novel Preformulations?
Tech Decoded 6
What Are the Main Contents of Crystallization Process Development?
Tech Decoded 5
The Power of SC-XRD & Polymorph Quantitation in Drug Development
Tech Decoded 4
Why Conduct Salts/Cocrystals Screening? How to Conduct Salts/Cocrystals Studies?
Tech Decoded 3
How to Conduct Polymorphic Screening Efficiently?
Tech Decoded 2
What is Solid-state Study During Drug Development and Why is it Necessary?
Tech Decoded 1
Porton Big Shot Talk | Dr. Pavlos Kouroupis
Join Dr. Pavlos Kouroupis, the Head of EU Business Development and SVP, takes you through Porton's global footprint and strategic roadmap. We firmly believe that forward-looking investments will solidify the foundation for business growth, achieving mutual benefits between clients and the company.
